Post Marketing Study on Pluvicto in Korea

Recruiting now

Conditions studied: Metastatic Castration-resistant Prostate Cancer

In brief

Post marketing study on Pluvicto in Korea

Key facts

Study ID

NCT06514521

Run by

Novartis Pharmaceuticals

People needed

278

Starts

2025-04-18

Expected to finish

2028-05-31

Last updated by the study team

2026-07-06

Who can join

Age: 18 and older, up to 100. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Study participants eligible for inclusion in this study must meet all of the following criteria:
• Male adult patient age ≥ 18
• Subject who are being treated with Pluvicto or whose treatment plan is finalized and scheduled to be administered at the time of consent by physician in accordance with the approved indication in South Korea
• Subject who provided the written informed consent prior to the study enrollment

You may not qualify if…

• Study participants meeting any of the following criteria are not eligible for inclusion in this study:
• Subject whose medical record is not accessible
• Subject who is not willing to provide the informed consent

Where it is running

• Novartis Investigative Site — Seongnam-si, Gyeonggi-do, South Korea (enrolling)
• Novartis Investigative Site — Suwon, Gyeonggi-do, South Korea (enrolling)
• Novartis Investigative Site — Busan, Korea, South Korea (enrolling)
• Novartis Investigative Site — Gyeonggi-do, Korea, South Korea (enrolling)
• Novartis Investigative Site — Seoul, Seoul, South Korea (enrolling)
• Novartis Investigative Site — Seoul, Seoul, South Korea (enrolling)
• Novartis Investigative Site — Jeollanam, South Korea (enrolling)
• Novartis Investigative Site — Seoul, South Korea (enrolling)
• Novartis Investigative Site — Seoul, South Korea (enrolling)
• Novartis Investigative Site — Seoul, South Korea (enrolling)
• Novartis Investigative Site — Seoul, South Korea (enrolling)
• Novartis Investigative Site — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.